Inactive

1.0 RFI TITLE: Dharmacon ON-TARGETplus™ Set of 4® Custom Library 460 Genes/Set of 4, 0.1 nmol 2.0 AGENCY: United States Army Medical Research Institute of Chemical Defense (USAMRICD) 3.0 OFFICE: Labor... 1.0 RFI TITLE: Dharmacon ON-TARGETplus™ Set of 4® Custom Library 460 Genes/Set of 4, 0.1 nmol 2.0 AGENCY: United States Army Medical Research Institute of Chemical Defense (USAMRICD) 3.0 OFFICE: Laboratory Services Branch, Research Support Division 4.0 LOCATION: Aberdeen Proving Grounds, MD 5.0 CONTRACTING OFFICE: U.S. Army Medical Research Acquisition Activity (USAMRAA), Fort Detrick, Frederick, MD. 6.0 SUBJECT: The USAMRAA, on behalf of USAMRICD, is conducting market research to identify available commercial solutions that meet the requirements for the delivery of Dharmacon ON-TARGETplus™ Set of 4® Custom Library 460 Genes/Set of 4, 0.1 nmol. This market research may also assist with the further development and/or refinement of the requirements. 7.0 DISCLAIMER: This is a Request for Information (RFI), as defined in FAR 15.201(e), to ascertain whether a commercial item exists that provides the capabilities described herein. This RFI is issued solely for information and planning purposes and does not constitute a solicitation. Neither unsolicited proposals nor any other kind of offers will be considered in response to this RFI. Responses to this notice are not offers and will not be accepted by the Government to form a binding contract. In keeping with the standards of FAR Part 10, the Government may request additional information from responders. Responders are solely responsible for all expenses associated with responding to this RFI or any follow-up information request. All information received in response to this RFI or any follow-up information request that is marked Proprietary will be handled accordingly. Responses to the RFI will not be returned. At this time, questions concerning the composition and requirements for a future request for proposal will not be entertained. 8.0 DESCRIPTION: The USAMRICD is a world-class organization and clear leader in medical research. As the Department of Defense's lead laboratory for the development of medical countermeasures against chemical threat agents, the USAMRICD is increasingly called upon to provide expert analytical and consultative services related to medical chemical defense research and to the medical management of chemical casualties. The USAMRICD requires Dharmacon ON-TARGETplus™ Set of 4® Custom Library 460 Genes/Set of 4, 0.1 nmol and shipping to USAMRICD located at the Aberdeen Proving Ground (APG) in Maryland. USAMRICD currently utilizes Dharmacon siRNA products to evaluate experimental systems. ON-TARGETplus is a Dharmacon proprietary modification to reduce off-target effects. In order to accomplish milestones with the necessary continuity under an approved funded research program, the USAMRICD requires the procurement of Dharmacon ON-TARGETplus™ Set of 4® Custom Library 460 Genes/Set of 4, 0.1 nmol. The Minimum Essential Characteristics (MECs) are provided in the attachment to this RFI. 9.0 SUBMISSION INSTRUCTIONS: Responses from all capable and qualified sources are encouraged to respond to this request. White papers should adhere to the following formatting and outline instructions: All submissions shall be made electronically and be in one of the following formats: Microsoft Word or Adobe PDF. Entities interested in submitting a response must furnish in writing, a 2-3 page (not including cover page, index or list of references) synopsis of their capability to provide the described product, including any necessary lead time. Companies responding to this notice must provide complete contact information (telephone, address, email address). Responders must identify their company’s business size (based on the NAICS size standard), business status (i.e. small business, disadvantaged, HUB zone, woman owned, service disabled veteran owned). Please also include information regarding any prior experience with U.S. Government contracts and experience performing this type of service. At this time no solicitation exists; therefore, please do not request a copy of the solicitation. 10.0 SUBMISSION CONTACT INFORMATION: Interested entities shall forward submissions electronically through email to Jesse Nisley at jesse.d.nisley.civ@mail.mil no later than 5:00pm Eastern Time, Thursday, 24 February 2022. NO PHONE CALLS will be accepted. No evaluation letters and/or results will be issued to the respondents. It is the responsibility of any potential offeror to monitor this site for the release of any solicitation or synopsis that follows this RFI.